The Korean Journal of Urological Oncology

REVIEW ARTICLE 2020 August 27 Epigenetic Approaches to the Treatment of Renal Cell Cancer
To summarize the epigenetics in renal cell carcinoma (RCC) and discuss the potential use of epigenetic modifiers as RCC biomarkers and treatments. Pertinent articles available on PubMed and google scholar database pertaining to kidney cancer and epigenetics were reviewed. Metast...

REVIEW ARTICLE 2020 August 27 Approaches for Personalized Drug Development in Bladder Cancer Patients
Bladder cancer, which affects the bladder mucosa, is the ninth most common disease worldwide. There are many types of cancerous tissue in the bladder. Most exhibit low malignancy, but their recurrence rate is higher in comparison to more malignant tissues. Only 10%–15% progress...

ORIGINAL ARTICLE 2020 August 27 Serum Testosterone Level Can Be Predictive Factor for Upstaging in Clinically Localized Prostate Cancer
Purpose: To determine an appropriate surgical technique, it is important to predict pathological results for patients with clinically localized prostate cancer (PCa) eligible for nerve-sparing radical prostatectomy (NSRP). Several studies have highlighted that serum testosterone...

Current Issue

Volume 18(2); August 2020

Volume 18(1); April 2020

Volume 17(3); December 2019

Volume 17(2); August 2019

Volume 17(1); April 2019

Review Articles

Therapeutic Options in High-Risk Nonmuscle Invasive Bladder Cancer During the Shortage of Bacillus Calmette-Guérin

Jeongwan Yoo, Yeon Joo Kim, Bum Sik Tae, Jae Young Park

Korean J Urol Oncol. 2020;18(2):73-77. Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.73

Epigenetic Approaches to the Treatment of Renal Cell Cancer

Seong Hwi Hong, Jiyoung Lee, Eun Bi Jang, Sung Yul Park, Hong-Sang Moon, Young Eun Yoon

Korean J Urol Oncol. 2020;18(2):78-90. Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.78

Approaches for Personalized Drug Development in Bladder Cancer Patients

Hyang Sook Seol, In Ho Chang

Korean J Urol Oncol. 2020;18(2):91-98. Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.91

New Androgen Receptor Axis-Targeted Agents in the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer: From Bench to Clinical Trials

Jeong Hee Hong

Korean J Urol Oncol. 2020;18(2):99-108. Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.99

Original Articles

109

Risk Factors for pT3a Prostate Cancer in the Patients With cT1-2 on Preoperative Multiparametric Magnetic Resonance Imaging

Kyung Hwan Kim, Ja Yoon Ku, Won Young Park, Seung Baek Hong, Suk Kim, Hong Koo Ha

Korean J Urol Oncol. 2020;18(2):109-115. Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.109

116

Serum Testosterone Level Can Be Predictive Factor for Upstaging in Clinically Localized Prostate Cancer

Soon Oh Kwon, Kyeong-Hyeon Byeon, Jae-Wook Chung, Yun-Sok Ha, Seock Hwan Choi, Bum Soo Kim, Hyun Tae Kim, Tae-Hwan Kim, Eun Sang Yoo, Ghil Suk Yoon, Jun Nyung Lee, Tae Gyun Kwon

Korean J Urol Oncol. 2020;18(2):116-123. Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.116

124

Management of Patients With Advanced Prostate Cancer: Establishment of Treatment Guidelines Through Prostate Cancer Summit (PCAS) 2016 Composed of Korean Prostate Cancer Experts

Chun Tae Jang, Hyung Joon Kim, Myung Ki Kim, Sung Woo Park, Seung Chol Park, Jae Young Park, Dong Hyeon Lee, Seung Hwan Lee, Hwang Gyun Jeon, Jae Hoon Chung, Hyeon Jeong, Moon Ki Jo, Sung-Hoo Hong, Cheol Kwak, Ji Youl Lee, Dong Deuk Kwon, Choung-Soo Kim, Seong Soo Jeon

Korean J Urol Oncol. 2020;18(2):124-139. Published online August 27, 2020
DOI: https://doi.org/10.22465/kjuo.2020.18.2.124